Key result
A 43-year-old female developed histologically confirmed severe acute myocarditis two days after receiving a third (booster) dose of the BNT162b2 mRNA COVID-19 vaccine.
Why the study?
mRNA COVID-19 vaccination is linked to myocarditis, typically mild and after the second dose, but cases after the third booster dose were not yet histologically characterized.
Case Report (n=1)
No
This case report highlights the potential for severe acute myocarditis to occur following a third (booster) dose of the BNT162b2 mRNA COVID-19 vaccine.
May warrant consideration of vaccine-associated myocarditis in post-booster cardiac presentations; leaves open population-level risk and causality.
Vaccination with mRNA vaccines against coronavirus disease 2019 (COVID-19) has been associated with a risk of developing myocarditis and pericarditis, with an estimated standardized incidence ratio of myocarditis being 5.34 (95% CI, 4.48 to 6.40) as compared to the expected incidence based on historical data according to a large national study in Israel. Most cases of myocarditis in vaccine recipients occur in young males, particularly following the second dose, and the presentation is usually mild. Recently, the third (booster) dose has been shown to reduce confirmed infections and severe illness even against common variants of the virus. In Israel, over 4.4 million citizens (more than 45% of the population) have been vaccinated with the third dose of Pfizer-BioNTech vaccine BNT162b2. Herein, we report the first case of a histologically confirmed severe myocarditis following the third dose of BNT162b2 COVID-19 vaccine.
No takes yet. Share an insight, caveat, or question.
Mengesha et al. (2022) conducted a case report in Severe Acute Myocarditis (n=1). BNT162b2 COVID-19 vaccine was evaluated on Histologically confirmed severe acute myocarditis. A 43-year-old female developed histologically confirmed severe acute myocarditis two days after receiving a third (booster) dose of the BNT162b2 mRNA COVID-19 vaccine.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: